These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2867883)

  • 1. Early use of beta-adrenergic-blocking agents in acute myocardial infarction.
    Mauro VF; Zeller FP
    Drug Intell Clin Pharm; 1986 Jan; 20(1):14-9. PubMed ID: 2867883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of beta blocker myocardial infarction trials.
    Goldstein S
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention with a beta-blocking drug after acute myocardial infarction.
    Hjalmarson A
    Am J Cardiol; 1984 Dec; 54(11):11E-13E. PubMed ID: 6150631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.
    Dahlström U; Berglund U; Karlsson E
    Acta Med Scand; 1980; 207(3):167-71. PubMed ID: 6102838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do beta-receptor blockers decrease mortality after myocardial infarction?
    Lichstein E
    J Am Coll Cardiol; 1985 Nov; 6(5):973-5. PubMed ID: 2864366
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta-receptor blockers in fresh myocardial infarct].
    Langenfeld H
    Dtsch Med Wochenschr; 1993 Oct; 118(43):1569-74. PubMed ID: 7900982
    [No Abstract]   [Full Text] [Related]  

  • 11. Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction: effects of beta-adrenergic blockade.
    Hohnloser SH; Zabel M; Olschewski M; Kasper W; Just H
    Am Heart J; 1992 Jun; 123(6):1530-5. PubMed ID: 1350703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
    Goldstein S
    Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P; Hammoude H; Degré S
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):155-61. PubMed ID: 2567590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.
    Maggioni AP; Zuanetti G; Franzosi MG; Rovelli F; Santoro E; Staszewsky L; Tavazzi L; Tognoni G
    Circulation; 1993 Feb; 87(2):312-22. PubMed ID: 8093865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can beta blockers limit myocardial infarct size?
    Hearse DJ; Yellon DM; Downey JM
    Eur Heart J; 1986 Nov; 7(11):925-30. PubMed ID: 2878807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Professor Peter Sleight's reflections on the use of beta-blocking agents after myocardial infarction.
    Sleight P
    Am Heart J; 1997 Aug; 134(2 Pt 2):S15-20. PubMed ID: 9313619
    [No Abstract]   [Full Text] [Related]  

  • 19. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis.
    Al-Reesi A; Al-Zadjali N; Perry J; Fergusson D; Al-Shamsi M; Al-Thagafi M; Stiell I
    CJEM; 2008 May; 10(3):215-23. PubMed ID: 19019272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation?
    Parratt JR
    Eur Heart J; 1986 Jul; 7 Suppl B():19-25. PubMed ID: 2875873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.